177 related articles for article (PubMed ID: 12680157)
1. Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study.
Hercbergs AA; Goyal LK; Suh JH; Lee S; Reddy CA; Cohen BH; Stevens GH; Reddy SK; Peereboom DM; Elson PJ; Gupta MK; Barnett GH
Anticancer Res; 2003; 23(1B):617-26. PubMed ID: 12680157
[TBL] [Abstract][Full Text] [Related]
2. Treatment of recurrent malignant gliomas with chronic oral high-dose tamoxifen.
Couldwell WT; Hinton DR; Surnock AA; DeGiorgio CM; Weiner LP; Apuzzo ML; Masri L; Law RE; Weiss MH
Clin Cancer Res; 1996 Apr; 2(4):619-22. PubMed ID: 9816211
[TBL] [Abstract][Full Text] [Related]
3. A phase I study of high-dose tamoxifen for the treatment of refractory malignant gliomas of childhood.
Pollack IF; DaRosso RC; Robertson PL; Jakacki RL; Mirro JR; Blatt J; Nicholson S; Packer RJ; Allen JC; Cisneros A; Jordan VC
Clin Cancer Res; 1997 Jul; 3(7):1109-15. PubMed ID: 9815790
[TBL] [Abstract][Full Text] [Related]
4. Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma.
Hau P; Fabel K; Baumgart U; Rümmele P; Grauer O; Bock A; Dietmaier C; Dietmaier W; Dietrich J; Dudel C; Hübner F; Jauch T; Drechsel E; Kleiter I; Wismeth C; Zellner A; Brawanski A; Steinbrecher A; Marienhagen J; Bogdahn U
Cancer; 2004 Mar; 100(6):1199-207. PubMed ID: 15022287
[TBL] [Abstract][Full Text] [Related]
5. Long-term response in high-grade optic glioma treated with medically induced hypothyroidism and carboplatin: a case report and review of the literature.
Ashur-Fabian O; Blumenthal DT; Bakon M; Nass D; Davis PJ; Hercbergs A
Anticancer Drugs; 2013 Mar; 24(3):315-23. PubMed ID: 23348245
[TBL] [Abstract][Full Text] [Related]
6. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
[TBL] [Abstract][Full Text] [Related]
7. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial.
Olivi A; Grossman SA; Tatter S; Barker F; Judy K; Olsen J; Bruce J; Hilt D; Fisher J; Piantadosi S;
J Clin Oncol; 2003 May; 21(9):1845-9. PubMed ID: 12721262
[TBL] [Abstract][Full Text] [Related]
8. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
[TBL] [Abstract][Full Text] [Related]
9. High dose oral tamoxifen and subcutaneous interferon alpha-2a for recurrent glioma.
Chang SM; Barker FG; Huhn SL; Nicholas MK; Page M; Rabbitt J; Prados MD
J Neurooncol; 1998 Apr; 37(2):169-76. PubMed ID: 9524096
[TBL] [Abstract][Full Text] [Related]
10. High-dose tamoxifen treatment increases the incidence of multifocal tumor recurrences in glioblastoma patients.
Puchner MJ; Giese A; Lohmann F; Cristante L
Anticancer Res; 2004; 24(6):4195-203. PubMed ID: 15736473
[TBL] [Abstract][Full Text] [Related]
11. Antithyroid drug therapy in hyperthyroidism. Recurrence, hypothyroidism and thyroid antibodies.
Stege R
Acta Chir Scand Suppl; 1980; 501():1-130. PubMed ID: 6163270
[No Abstract] [Full Text] [Related]
12. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.
Durando X; Lemaire JJ; Tortochaux J; Van-Praagh I; Kwiatkowski F; Vincent C; Bailly C; Verrelle P; Irthum B; Chazal J; Bay JO
Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621
[TBL] [Abstract][Full Text] [Related]
13. Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy.
Preul MC; Caramanos Z; Villemure JG; Shenouda G; LeBlanc R; Langleben A; Arnold DL
Neurosurgery; 2000 Feb; 46(2):306-18. PubMed ID: 10690719
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
Akin F; Yaylali GF; Turgut S; Kaptanoglu B
Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
[TBL] [Abstract][Full Text] [Related]
15. Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.
Wen PY; Yung WK; Lamborn KR; Dahia PL; Wang Y; Peng B; Abrey LE; Raizer J; Cloughesy TF; Fink K; Gilbert M; Chang S; Junck L; Schiff D; Lieberman F; Fine HA; Mehta M; Robins HI; DeAngelis LM; Groves MD; Puduvalli VK; Levin V; Conrad C; Maher EA; Aldape K; Hayes M; Letvak L; Egorin MJ; Capdeville R; Kaplan R; Murgo AJ; Stiles C; Prados MD
Clin Cancer Res; 2006 Aug; 12(16):4899-907. PubMed ID: 16914578
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy protocol "8 drugs in 1 day" in patients with recurrent malignant glioma].
Jeremić B; Grujicić D; Matović M
Srp Arh Celok Lek; 1994; 122(3-4):73-5. PubMed ID: 17972813
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
Kesari S; Schiff D; Doherty L; Gigas DC; Batchelor TT; Muzikansky A; O'Neill A; Drappatz J; Chen-Plotkin AS; Ramakrishna N; Weiss SE; Levy B; Bradshaw J; Kracher J; Laforme A; Black PM; Folkman J; Kieran M; Wen PY
Neuro Oncol; 2007 Jul; 9(3):354-63. PubMed ID: 17452651
[TBL] [Abstract][Full Text] [Related]
18. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy in supratentorial gliomas. A study of 821 cases.
Heesters M; Molenaar W; Go GK
Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
[TBL] [Abstract][Full Text] [Related]
20. Use of tamoxifen in asymptomatic patients with recurrent small-volume ovarian cancer.
Markman M; Webster K; Zanotti K; Rohl J; Belinson J
Gynecol Oncol; 2004 May; 93(2):390-3. PubMed ID: 15099951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
